Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Proteomics Research
4.2.2 Rising Prevalence of Cancer
4.3 Market Restraints
4.3.1 Lack of Skilled Labour
4.3.2 High Cost of Stable Isotope-Labeled Compounds
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Deuterium
5.1.2 Carbon-13
5.1.3 Oxygen-18
5.1.4 Other Stable Isotopes
5.2 By Application
5.2.1 Research and Development
5.2.2 Clinical Diagnostics
5.2.3 Other Applications
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 PerkinElmer Inc
6.1.2 Merck KGaA
6.1.3 Cambridge Isotope Laboratories, Inc.
6.1.4 JSC Isotope.
6.1.5 Medical Isotopes, Inc.
6.1.6 Omicron Biochemicals, Inc.
6.1.7 Trace Sciences International
6.1.8 Alsachim
6.1.9 Taiyo Nippon Sanso Corporation


7 MARKET OPPORTUNITIES AND FUTURE TRENDS